These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15801541)

  • 1. Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors.
    Fujino H; Saito T; Tsunenari Y; Kojima J; Sakaeda T
    Xenobiotica; 2004; 34(11-12):961-71. PubMed ID: 15801541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.
    Sakaeda T; Fujino H; Komoto C; Kakumoto M; Jin JS; Iwaki K; Nishiguchi K; Nakamura T; Okamura N; Okumura K
    Pharm Res; 2006 Mar; 23(3):506-12. PubMed ID: 16388406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.
    Fujino H; Yamada I; Shimada S; Yoneda M; Kojima J
    Xenobiotica; 2003 Jan; 33(1):27-41. PubMed ID: 12519692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins.
    Filppula AM; Hirvensalo P; Parviainen H; Ivaska VE; Lönnberg KI; Deng F; Viinamäki J; Kurkela M; Neuvonen M; Niemi M
    Drug Metab Dispos; 2021 Aug; 49(8):658-667. PubMed ID: 34045219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between several medicines and statins.
    Fujino H; Saito T; Tsunenari Y; Kojima J
    Arzneimittelforschung; 2003; 53(3):145-53. PubMed ID: 12705168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.
    Ishigami M; Honda T; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2001 Mar; 29(3):282-8. PubMed ID: 11181496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
    Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA
    Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).
    Shiozawa A; Yamaori S; Kamijo S; Ohmori S
    Drug Metab Pharmacokinet; 2021 Feb; 36():100364. PubMed ID: 33341662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.
    Shitara Y; Sugiyama Y
    Pharmacol Ther; 2006 Oct; 112(1):71-105. PubMed ID: 16714062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics.
    Neuvonen PJ
    Curr Opin Investig Drugs; 2010 Mar; 11(3):323-32. PubMed ID: 20178046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D; Feely J
    Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
    Jacobsen W; Kuhn B; Soldner A; Kirchner G; Sewing KF; Kollman PA; Benet LZ; Christians U
    Drug Metab Dispos; 2000 Nov; 28(11):1369-78. PubMed ID: 11038166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes.
    Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between fibrates and statins--metabolic interactions with gemfibrozil.
    Fujino H; Yamada I; Shimada S; Hirano M; Tsunenari Y; Kojima J
    Drug Metabol Drug Interact; 2003; 19(3):161-76. PubMed ID: 14682608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential changes in the pharmacokinetics of statins in collagen-induced arthritis rats.
    Lin CH; Hsu KW; Chen CH; Uang YS; Lin CJ
    Biochem Pharmacol; 2017 Oct; 142():216-228. PubMed ID: 28636885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans.
    Yamada I; Fujino H; Shimada S; Kojima J
    Xenobiotica; 2003 Jul; 33(7):789-803. PubMed ID: 12893526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.
    Kajinami K; Takekoshi N; Saito Y
    Cardiovasc Drug Rev; 2003; 21(3):199-215. PubMed ID: 12931254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
    Tornio A; Pasanen MK; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):104-8. PubMed ID: 15998357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions that interfere with statin metabolism.
    Hirota T; Ieiri I
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.